Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sudhir Manda
Comorbidities Predict Inferior Outcomes in Chronic Lymphocytic Leukemia Treated With Ibrutinib
Cancer
Cancer Research
Oncology
Related publications
Beyond Ibrutinib Resistance in Chronic Lymphocytic Leukemia
Cancer therapy & Oncology International Journal
Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Arresting the Inflammatory Drive of Chronic Lymphocytic Leukemia With Ibrutinib
Clinical Cancer Research
Cancer Research
Oncology
Amebic Encephalitis in a Patient With Chronic Lymphocytic Leukemia on Ibrutinib Therapy
Case Reports in Hematology
Addition of Venetoclax at Time of Progression in Ibrutinib‐treated Patients With Chronic Lymphocytic Leukemia: Combination Therapy to Prevent Ibrutinib Flare
American Journal of Hematology
Hematology
Experience With Ibrutinib in Patients With Refractory and Recurrent B-Cell Chronic Lymphocytic Leukemia
Medical Council
Successful Treatment of Chronic Lymphocytic Leukemia Mutlifocal Central Nervous System Involvement With Ibrutinib
Turkish Journal of Haematology
Hematology
Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide
Clinical Journal of Oncology Nursing
Oncology
DNA Methylation Profiles in Chronic Lymphocytic Leukemia Patients Treated With Chemoimmunotherapy
Clinical Epigenetics
Genetics
Developmental Biology
Molecular Biology
